Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$269,558
-$81,410 QoQ
Shares Held
1,720
-58.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,185
of 1,603 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF HAWAII holds $33,752,794 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,030 | $9,150,539 | |
| 2 | LLY |
ELI LILLY & Co
|
5,999 | $7,195,380 | |
| 3 | ABBV |
AbbVie Inc.
|
27,871 | $7,013,457 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,915 | $5,000,577 | |
| 5 | BIIB |
Biogen Inc.
|
6,780 | $1,464,886 | |
| 6 | PFE |
Pfizer Inc
|
41,818 | $1,006,977 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,468 | $718,406 | |
| 8 | NVO |
Novo Nordisk A S
|
14,016 | $671,927 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $269,558 | 1,720 | Shares | Defined | 2026-08-14 | |
| 2022-06-30 | $350,968 | 4,152 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $357,405 | 4,073 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $301,684 | 3,449 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $293,835 | 3,593 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $419,247 | 4,595 | Shares | Defined | 2021-07-22 | |
| 2021-03-31 | $477,747 | 5,589 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $473,944 | 5,019 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $351,231 | 4,039 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||